Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel Schiff

Showing results (11-20 of 199) with videos related to

Pageof 20
Sort By:
Endocrine-Related Cancer|January 30, 2007
Resistance to endocrine therapy in breast cancer: exploiting estrogen receptor/growth factor signaling crosstalkSuleiman Massarweh, Rachel Schiff
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2007
Unraveling the mechanisms of endocrine resistance in breast cancer: new therapeutic opportunitiesSuleiman Massarweh, Rachel Schiff
Frontiers in Psychology|October 14, 2014
Does complexity matter? Meta-analysis of learner performance in artificial grammar tasksRachel Schiff, Pesia Katan
Archives of Pathology & Laboratory Medicine|January 6, 2011
HER2: biology, detection, and clinical implicationsCarolina Gutierrez, Rachel Schiff
Cancer Discovery|November 3, 2018
Is ctDNA the Road Map to the Landscape of the Clonal Mutational Evolution in Drug Resistance? Lessons from the PALOMA-3 Study and Implications for Precision MedicineRachel Schiff, Rinath Jeselsohn
Dyslexia (Chichester, England)|June 18, 2026
Script-Specific Predictors of Reading Comprehension in Hebrew-Speaking Children With Reading DifficultiesRachel Schiff, Ayelet Sasson
Annual Review of Medicine|October 5, 2010
Mechanisms of endocrine resistance in breast cancerC Kent Osborne, Rachel Schiff
The Journal of Steroid Biochemistry and Molecular Biology|July 16, 2005
Aromatase inhibitors: future directionsC Kent Osborne, Rachel Schiff
Frontiers in Psychology|April 25, 2018
Development and Relationships Between Phonological Awareness, Morphological Awareness and Word Reading in Spoken and Standard ArabicRachel Schiff, Elinor Saiegh-Haddad
Nature Clinical Practice. Oncology|March 8, 2006
Can biomarkers direct the optimal use of aromatase inhibitors versus selective estrogen receptor modulators?Rachel Schiff, Adrian V Lee
Pageof 20

Showing results (11-20 of 199) with videos related to

Sort By:
Pageof 20
Endocrine-Related Cancer|January 30, 2007
Resistance to endocrine therapy in breast cancer: exploiting estrogen receptor/growth factor signaling crosstalkSuleiman Massarweh, Rachel Schiff
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2007
Unraveling the mechanisms of endocrine resistance in breast cancer: new therapeutic opportunitiesSuleiman Massarweh, Rachel Schiff
Frontiers in Psychology|October 14, 2014
Does complexity matter? Meta-analysis of learner performance in artificial grammar tasksRachel Schiff, Pesia Katan
Archives of Pathology & Laboratory Medicine|January 6, 2011
HER2: biology, detection, and clinical implicationsCarolina Gutierrez, Rachel Schiff
Cancer Discovery|November 3, 2018
Is ctDNA the Road Map to the Landscape of the Clonal Mutational Evolution in Drug Resistance? Lessons from the PALOMA-3 Study and Implications for Precision MedicineRachel Schiff, Rinath Jeselsohn
Dyslexia (Chichester, England)|June 18, 2026
Script-Specific Predictors of Reading Comprehension in Hebrew-Speaking Children With Reading DifficultiesRachel Schiff, Ayelet Sasson
Annual Review of Medicine|October 5, 2010
Mechanisms of endocrine resistance in breast cancerC Kent Osborne, Rachel Schiff
The Journal of Steroid Biochemistry and Molecular Biology|July 16, 2005
Aromatase inhibitors: future directionsC Kent Osborne, Rachel Schiff
Frontiers in Psychology|April 25, 2018
Development and Relationships Between Phonological Awareness, Morphological Awareness and Word Reading in Spoken and Standard ArabicRachel Schiff, Elinor Saiegh-Haddad
Nature Clinical Practice. Oncology|March 8, 2006
Can biomarkers direct the optimal use of aromatase inhibitors versus selective estrogen receptor modulators?Rachel Schiff, Adrian V Lee
Pageof 20